Outsourcing Biologics: Key Considerations

Biologics are a more complex class of pharmaceuticals to manufacture, package, store and distribute than their chemical counterparts.

HPAPI Manufacturing – Choosing The Right CDMO

Safe handling of highly potent molecules is complex, and the associated regulatory requirements are growing. As a result, pharmaceutical companies recognize the importance of selecting the right partner for the development.

Driving Digital Transformation in the Pharma Industry – Executive Q&A

Digital Transformation in the Pharma Industry means accessibility is key, consumers are accustomed to experiencing convenience across all aspects of their lives.

An Evolving Biologics Landscape and Driving Innovation and Opportunity

WHITEPAPER: The trend toward biologics and greater investment in small and emerging biotech companies is clearly reflected by our experience at PCI Pharma Services.

PCI Pharma Services Uses AWS to Bridge the Gap Between Life-changing Therapies and Patients

PCI Pharma Services built pci | bridge on AWS as part of a larger digital transformation, helping the company to more efficiently provide secure, real-time data to its customers.

Biologics Development, Manufacturing & Packaging

A panel of experts from PCI Pharma Services and three Life Sciences companies discuss challenges and opportunities related to the development, clinical phases and commercialization of biologics, offering insights on how to improve sponsor-CDMO

The trusted partner for global integrated CDMO services.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Start your PCI experience today.

Your bridge between life-changing therapies and patients.